Janus Henderson Short Duration Flexible Bond Fund returned 1.54% and the Bloomberg 1-3 Year U.S. Government/Credit Index ...

Gary Danielson will serve as color commentator for the CBS Sports broadcast of the 126th Army-Navy Game Saturday afternoon at ...

Banks lead preferred issuance with steady income benefits and defensive qualities that strengthen portfolios. See why our top ...

Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...

Mike Mazzei has a background in both public and private work in Oklahoma, serving as a state senator for 12 years and later ...

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...

KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...

After another wild year for the industry, the women making the biggest impact across film and television reveal their ...

Objective response rate (ORR) of 75.0% including three very good partial responses (VGPR) in heavily pre-treated Waldenström ...

Through the agreement, American Antimony will supply test shipments of high-grade antimony ore for evaluation under the terms outlined in a Scope of Work , which governs the sampling, testing, and ...

We came across a bearish thesis on Okta, Inc. on Monopolistic Investor’s Substack by Antoni Nabzdyk. In this article, we will summarize the bulls’ thesis on OKTA. Okta, Inc.’s share was trading at $81 ...

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line1 ...